Eliza Hawkes

Dr

20072019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2007 2019

Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphoma

Ratnasingam, S., Casan, J., Shortt, J., Hawkes, E., Gilbertson, M., McQuilten, Z., Grigoriadis, G., Htun, K. T., Htet, S. M., Campbell, P., Chai, K. L., Quach, H., Patil, S. & Opat, S., 19 Sep 2019, In : Scientific Reports. 9, 1, 7 p., 13544.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care

Casan, J. ML., Barraclough, A., Shortt, J. & Hawkes, E. A., 1 Mar 2019, In : The Lancet Haematology. 6, 3, p. e119 1 p.

Research output: Contribution to journalLetterOtherpeer-review

1 Citation (Scopus)

Efficacy and toxicity of PACEBOM chemotherapy in relapsed/refractory aggressive lymphoma in the rituximab era

Tamjid, B., Mckendrick, J., Schwarer, A., Doig, R., James, P., Hosking, P. & Hawkes, E. A., 1 Jun 2017, In : Asia-Pacific Journal of Clinical Oncology. 13, 3, p. 226-233 8 p.

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)

Is upfront escalated BEACOPP for advanced Hodgkin lymphoma becoming a distant memory?

Hawkes, E. A., Chong, G. & Grigg, A., 20 Jan 2017, In : Journal of Clinical Oncology. 35, 3, p. 371-372 2 p.

Research output: Contribution to journalLetterOtherpeer-review